Ming Hsieh Fulgent Genetics, Inc. (FLGT) insider trading activity

Ming Hsieh is Chief Executive Officer of Fulgent Genetics, Inc.. Currently has a direct ownership of 817,078 shares of FLGT, which is worth approximately $15.2 Million. The most recent transaction as insider was on Feb 26, 2025, when has been sold 11,773 shares (Common Stock) at a price of $16.24 per share, resulting in proceeds of $191,193. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 817K

16.11% 3M change

26.01% 12M change

Total Value Held $15.2 Million

Ming Hsieh Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 26 2025	SELL Payment of exercise price or tax liability	$191,193 $16.24 p/Share	11,773 Reduced 1.42%	817,078 Common Stock
Feb 25 2025	SELL Payment of exercise price or tax liability	$579,614 $16.29 p/Share	35,581 Reduced 4.64%	730,631 Common Stock
Feb 25 2025	BUY Grant, award, or other acquisition	-	164,517 Added 16.56%	828,851 Common Stock
Feb 23 2025	SELL Payment of exercise price or tax liability	$38,253 $16.46 p/Share	2,324 Reduced 0.33%	699,915 Common Stock
Feb 01 2025	SELL Payment of exercise price or tax liability	$24,494 $16.64 p/Share	1,472 Reduced 0.21%	702,239 Common Stock
Nov 25 2024	SELL Open market or private sale	$40,665 $18.26 p/Share	2,227 Reduced 0.32%	703,711 Common Stock
Nov 01 2024	SELL Payment of exercise price or tax liability	$28,892 $21.61 p/Share	1,337 Reduced 0.19%	705,938 Common Stock
Aug 27 2024	SELL Open market or private sale	$52,805 $22.83 p/Share	2,313 Reduced 0.33%	707,275 Common Stock
Aug 01 2024	SELL Payment of exercise price or tax liability	$31,513 $23.57 p/Share	1,337 Reduced 0.19%	709,588 Common Stock
May 23 2024	SELL Payment of exercise price or tax liability	$44,626 $21.14 p/Share	2,111 Reduced 0.3%	710,925 Common Stock
May 01 2024	SELL Payment of exercise price or tax liability	$27,675 $20.7 p/Share	1,337 Reduced 0.19%	713,036 Common Stock
Feb 26 2024	SELL Payment of exercise price or tax liability	$437,893 $24.26 p/Share	18,050 Reduced 2.71%	648,421 Common Stock
Feb 26 2024	BUY Grant, award, or other acquisition	-	99,721 Added 12.25%	714,373 Common Stock
Feb 23 2024	SELL Payment of exercise price or tax liability	$208,528 $24.06 p/Share	8,667 Reduced 1.35%	632,702 Common Stock
Feb 01 2024	SELL Payment of exercise price or tax liability	$27,339 $24.99 p/Share	1,094 Reduced 0.17%	641,369 Common Stock
Nov 01 2023	SELL Payment of exercise price or tax liability	$31,088 $23.75 p/Share	1,309 Reduced 0.2%	642,463 Common Stock
Aug 01 2023	SELL Payment of exercise price or tax liability	$185,723 $38.83 p/Share	4,783 Reduced 0.74%	643,772 Common Stock
Feb 23 2023	SELL Payment of exercise price or tax liability	$83,081 $31.65 p/Share	2,625 Reduced 0.4%	648,555 Common Stock
Feb 23 2023	BUY Grant, award, or other acquisition	-	55,009 Added 7.79%	651,180 Common Stock
Nov 07 2022	BUY Grant, award, or other acquisition	$22,091,992 $39.02 p/Share	566,171 Added 48.71%	596,171 Common Stock
Aug 01 2022	BUY Grant, award, or other acquisition	-	30,000 Added 50.0%	30,000 Common Stock

Also insider at

FTNT

Fortinet, Inc. Technology

Ming Hsieh

Chief Executive Officer

Temple City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FLGT shares.

Notify only if

Value

Insider Trading

Get notified when an Fulgent Genetics, Inc. insider buys or sells FLGT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Fulgent Genetics, Inc.

Track Activities on FLGT

Account